Drug Patents owned by Cubist Pharms

1. Drug name - ENTEREG

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8946262 CUBIST PHARMS Methods of preventing and treating gastrointestinal dysfunction Feb, 2030

(7 years from now)

Drugs and Companies using ALVIMOPAN ingredient

Treatment: A method to accelerate the time to gastrointestinal recovery by administering about 12 mg of alvimopan to the patient from about 30 to 60 minutes prior to surgery


More Information on Dosage
Strength Dosage Availability
12MG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.